ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

ClinicalTrials.gov ID: NCT02121418

Public ClinicalTrials.gov record NCT02121418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly Acute Myeloid Leukemia (AML) and Advanced Myelodysplastic Syndrome (MDS)

Study identification

NCT ID
NCT02121418
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of Washington
Other
Enrollment
12 participants

Conditions and interventions

Interventions

  • Cytarabine Drug
  • Decitabine Drug
  • Laboratory Biomarker Analysis Other

Drug · Other

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Feb 7, 2017
Completion
Feb 13, 2018
Last update posted
Apr 12, 2018

2014 – 2018

United States locations

U.S. sites
9
U.S. states
2
U.S. cities
9
Facility City State ZIP Site status
Bozeman Deaconess Hospital Bozeman Montana 59715
Kadlec Clinic Hematology and Oncology Kennewick Washington 99336
EvergreenHealth Medical Center Kirkland Washington 98033
Skagit Valley Hospital Mount Vernon Washington 98274
Olympic Medical Center Port Angeles Washington 98362
Group Health Cooperative Redmond Washington 98052
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109
Multicare Health System Tacoma Washington 98415
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02121418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2018 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02121418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →